International Journal of Cardiology
Volume 76, Issue 2 , Pages 147-156 , November 2000

Short- and long-term risk factors for sudden death in patients with stable angina

  • Daniel Benchimol, MD

      Affiliations

    • Service de Cardiologie et Maladies Vasculaires, Hôpital Cardiologique, 33604 Pessac, France
    • ,
  • Bénédicte Dubroca, BA

      Affiliations

    • Laboratoire de Biostatistiques et d’Epidémiologie, Université Victor Segalen Bordeaux 2, INSERM Unité 330, 33076 Bordeaux, France
    • ,
  • Virginie Bernard, MD

      Affiliations

    • Service de Cardiologie et Maladies Vasculaires, Hôpital Cardiologique, 33604 Pessac, France
    • ,
  • Julie Lavie, PhD

      Affiliations

    • INSERM Unité 441, Athérosclérose, Avenue du Haut-Lévêque, 33600 Pessac, France
    • ,
  • Bertrand Paviot, MS

      Affiliations

    • Service de Cardiologie et Maladies Vasculaires, Hôpital Cardiologique, 33604 Pessac, France
    • ,
  • Hélène Benchimol, MD

      Affiliations

    • Service de Cardiologie et Maladies Vasculaires, Hôpital Cardiologique, 33604 Pessac, France
    • ,
  • Thierry Couffinhal, MD PhD

      Affiliations

    • Service de Cardiologie et Maladies Vasculaires, Hôpital Cardiologique, 33604 Pessac, France
    • INSERM Unité 441, Athérosclérose, Avenue du Haut-Lévêque, 33600 Pessac, France
    • ,
  • Xavier Pillois, PhD

      Affiliations

    • INSERM Unité 441, Athérosclérose, Avenue du Haut-Lévêque, 33600 Pessac, France
    • ,
  • Jean-François Dartigues, MD PhD

      Affiliations

    • INSERM Unité 441, Athérosclérose, Avenue du Haut-Lévêque, 33600 Pessac, France
    • ,
  • Jacques Bonnet, MD

      Affiliations

    • Service de Cardiologie et Maladies Vasculaires, Hôpital Cardiologique, 33604 Pessac, France
    • INSERM Unité 441, Athérosclérose, Avenue du Haut-Lévêque, 33600 Pessac, France
    • Corresponding Author InformationTel.: +33-557-891970; fax: +33-556-368979

Received 17 January 2000 ,Revised 15 August 2000 ,Accepted 4 September 2000.

References 

  1. Myerburg R, Kessler K, Bassett A, Castellanos A. A biological approach to sudden cardiac death. Structure, function, and cause. Am J Cardiol. 1989;15:1512–1516
  2. Kannel WB, Doyle JT, McNamara PM, Quickenton P, Gordon T. Precursors of sudden coronary death: factors related to the incidence of sudden death. Circulation. 1975;51:606–613
  3. Doyle JT, Kannel WB, McNamara PM, Quickenton P, Gordon T. Factors related to suddenness of death from coronary disease: Combined Albany–Framingham studies. Am J Cardiol. 1976;37:1073–1078
  4. Bigger JT, Fleiss JL, Kleiger R, Miller JP, Rolnitzky LM. The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction. Circulation. 1984;54:250–258
  5. Malmberg K, Bavenholm P, Hamsten A. Clinical and biochemical factors associated with prognosis after myocardial infarction at a young age. J Am Coll Cardiol. 1994;24:592–599
  6. Myerburg R, Kessler K, Castellanos A. Sudden cardiac death. Structure, function and time-dependence of risk. Circulation. 1992;85(Suppl I):I2–I10
  7. Furukawa T, Rozanski JJ, Nogami A, Moroe K, Gosselin AJ, Lister JW. Time-dependent risk of and predictors for cardiac arrest recurrence in survivors of out-of-hospital cardiac arrest with chronic coronary artery disease. Circulation. 1989;80:599–608
  8. Thompson SG, Kienast J, Pyke SDM, Havertake F, Van de Loo JCW. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med. 1995;332:635–641
  9. Benchimol D, Dartigues JF, Benchimol H, et al.  Predictive value of hemostatic factors for sudden death in patients with stable angina pectoris. Am J Cardiol. 1995;76:241–244
  10. Cuppples LA, Gagnon D, Kannel W. Long-and short-term risk of sudden coronary death. Circulation. 1992;85(Suppl I):I11–I18
  11. Davies MJ, Thomas AC. Thrombosis and acute coronary artery lesion in sudden cardiac ischemic death. N Engl J Med. 1984;310:1137–1140
  12. Goldstein S. Toward a new understanding of the mechanism and prevention of sudden death in coronary heart disease. Circulation. 1990;82:284–288
  13. Rose GA, Blackburn H. Cardiovascular survey methods. Geneva: World Health Organization; 1968;
  14. Criqui MH, Fronek A, Klauber MR, Barret-Connor E, Gabriel S. The sensitivity, specificity and predictive value of traditional clinical evaluation of peripheral arterial disease: results from noninvasive testing in a defined population. Circulation. 1985;71:516–522
  15. Levy D, Labib SB, Anderson KM, Christiansen JC, Kannel WB, Castelli WP. Determinants of sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophy. Circulation. 1990;81:815–820
  16. Claus A. Gerinnungsphysiologische schnellmenthode zur bestimmung des fibrinogens. Acta Haematol. 1957;17:237–246
  17. Kluft C, Brakman P, Veldhyyzn-Stolk EC. Screening of fibrinolytic activity in the plasma euglobulin fractions on the fibrin plate. In:  Davidson JF,  Samama M,  Desnoyerse PC editor. Progress in chemical fibrinolysis and thrombosis. New York: Raven Press; 1976;p. 257–265
  18. Verheijen JH, Mullaart E, Chang GTG, Kluft C, Wijngaards G. A simple sensitive spectrophotometric assay for extrinsix (tissue type) plasminogen activator applicable to measurement in plasma. Thromb Haemost. 1982;48:266–269
  19. Ericksson E, Ranby M, Grysander E, Risberg B. Determination of plasminogen activator inhibitor in plasma using tPA and chromogenic single point poly-d-lysine stimulated assay. Thromb Res. 1988;50:91–101
  20. Rijken DC, Juhan-Vague I, Collen D. Complexes between extrinsic plasminogen activator and proteinase inhibitors in human plasma identified with an immunoradiometric assay. J Lab Clin Med. 1983;10:285–294
  21. Brunelli C, Cristofani R, L’Abbate A for the OD1 study group. Long-term survival in medically treated patients with ischaemic heart disease and prognostic importance of clinical and electrocardiographic data. Eur Heart J 1989;10:292–303.
  22. Holmes DR, Davis K, Gersh BJ, Mock MB, Pettinger MB and participants in the coronary artery surgery study (CASS). Risk factor profiles of patients with sudden cardiac death and death from other cardiac causes: a report from the Coronary Artery Study (CASS). J Am Coll Cardiol 1989;13:524–530.
  23. Rockman HA, Juneau C, Chatterjee K, Rouleau JL. Long-term predictors of sudden and low output death in chronic congestive heart failure secondary to coronary artery disease. Am J Cardiol. 1989;64:1344–1348
  24. Criqui MH, Coughlin SS, Fronek A. Non-invasively diagnosed peripheral arterial disease as a predictor of mortality: results from a prospective study. Circulation. 1985;72:768–773
  25. Davey-Smith G, Shipley MJ, Rose G. Intermittent claudication, heart disease risk factors and mortality. The Whitehall Study. Circulation. 1990;82:1925–1931
  26. Behar S, Zion M, Reicher-Reiss H, Kaplinsky E, Goldbourt U for the Sprint Study Group. Short- and long-term prognosis of patients with a first acute myocardial infarction with concomitant peripheral vascular disease. Am J Med 1994;96:15–19.
  27. Jansson JH, Olofsson BO, Nilsson TK. Predictive value of tissue plasminogen activator mass concentration on long-term mortality in patients with coronary artery disease. A 7-year follow-up. Circulation. 1993;88(part 1):2030–2034
  28. Van der Bom JG, de Knijff P, Haverkate F, et al.  Tissue plasminogen activator and risk of myocardial infarction. The Rotterdam Study. Circulation. 1997;95:2263–2267
  29. Held C, Hjemdahl P, Rehnqvist N, et al.  Fibrinolytic variables and cardiovascular prognosis in patients with stable angina pectoris treated by verapamil or metoprolol. results from the angina prognosis study in Stokholm. Circulation. 1997;95:2380–2386
  30. Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation. 1983;67:968–977
  31. Jouven X, Desnos M, Guerot C, Ducimetiere P. Predicting sudden death in the population. The Paris prospective study I. Circulation. 1999;99:1978–1983
  32. Kannel WB, Wolf PA, Castelli WP, D’Agostino RB. Fibrinogen and risk of cardiovascular disease. The Framingham Study. J. Am. Med. Assoc. 1987;258:1183–1186
  33. Meade TW, Mellows S, Brozovic M, et al.  Haemostatic function and ischemic heart disease: principal results of the Northwick Park heart study. Lancet. 1986;2:533–537
  34. Folsom AR, Wu KK, Rosamond WD, Sharrett AR, Chambless LE. Prospective study of hemostatic factors and incidence of coronary heart disease. The atherosclerotic risk in communities (ARIC) study. Circulation. 1997;96:1102–1108
  35. Juhan-Vague I, Pyke SDM, Alessi MC, Jespersen J, Haverkate F, Thompson SG on the behalf of the ECAT study group. Fibrinolytic factors and risk of myocardial infarction or sudden death in patients with stable angina pectoris. Circulation 1996;94:2057–2063.
  36. Theroux P, Fuster V. Acute coronary syndromes. Unstable angina and non-Q-wave myocardial infarction. Circulation. 1998;97:1195–1206

PII: S0167-5273(00)00370-3

International Journal of Cardiology
Volume 76, Issue 2 , Pages 147-156 , November 2000

Article Tools

* Image Usage & Resolution